Reducing Platelet Outdating Cost, an Important Advantage of Pathogen-Reduction Technology

被引：0
|
作者：
Jimenez-Marco, T. [1 ]
Bautista-Gili, A. [1 ]
Girona-Llobera, E. [1 ]
机构：
[1] Fundacio Banc Sang & Teixits Illes Balears, Palma De Mallorca, Spain
来源：
TRANSFUSION | 2014年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SP81
引用
收藏
页码：87A / 87A
页数：1
相关论文
共 50 条
  • [41] How do we implement pathogen reduction technology, while maintaining an adequate platelet inventory for our patients?
    Nguyen, Jennifer T.
    Rioveros, Jowin
    Ziman, Alyssa
    McGonigle, Andrea
    Ward, Dawn C.
    [J]. TRANSFUSION, 2021, 61 (04) : 1014 - 1022
  • [42] LYMPHOCYTE SURVIVAL/ACTIVATION IN STORED PLATELET CONCENTRATES FOLLOWING GAMMA-IRRADIATION OR PATHOGEN REDUCTION TECHNOLOGY TREATMENT
    Antoniewicz-Papis, J.
    Wozniak, J.
    Krzywdzinska, A.
    Janik, K.
    Rosiek, A.
    Lachert, E.
    Kopec-Szlezak, J.
    Dzieciatkowska, A.
    Letowska, M.
    [J]. VOX SANGUINIS, 2010, 99 : 18 - 18
  • [43] Neutrophil Priming Activity in Platelet Concentrates (PCs) Collected by Apheresis and Treated with Mirasol® Pathogen Reduction Technology (PRT)
    Ambruso, D. R.
    Thurman, G.
    Tran, K.
    Marschner, S.
    Goodrich, R. P.
    [J]. TRANSFUSION, 2009, 49 : 9A - 9A
  • [44] A HEALTH ECONOMIC EVALUATION OF THE IMPACT OF PATHOGEN REDUCTION TECHNOLOGY ON EMERGING PATHOGENS WITHIN THE PLATELET COLLECTION AND TRANSFUSION SPACE
    Dierick, K.
    Sweerts, L.
    Lee, Y.
    Cardoso, M.
    [J]. VALUE IN HEALTH, 2020, 23 : S578 - S578
  • [45] Our experience in riboflavin and ultraviolet light pathogen reduction technology for platelets: from platelet production to patient care
    Jimenez-Marco, Teresa
    Garcia-Recio, Marta
    Girona-Llobera, Enrique
    [J]. TRANSFUSION, 2018, 58 (08) : 1881 - 1889
  • [46] Inactivation of human white blood cells in platelet products after pathogen reduction technology treatment in comparison to gamma irradiation
    Fast, Loren D.
    DiLeone, Gilbert
    Marschner, Susanne
    [J]. TRANSFUSION, 2011, 51 (07) : 1397 - 1404
  • [47] Clinical and economic impacts of large volume delayed sampling and pathogen reduction technology platelet processing strategies in the United States
    Earnshaw, Stephanie
    Beyhaghi, Hadi
    McDade, Cheryl
    Purser, Molly
    Marriott, Robert
    Daane, Lori
    Le Coent, Virginie
    Yang, Julie
    Toback, Seth
    [J]. TRANSFUSION, 2021, 61 (10) : 2885 - 2897
  • [48] WHO REPOSITORY TRANSFUSION-RELEVANT BACTERIA REFERENCE STRAINS AS A TOOL FOR VALIDATION OF PATHOGEN REDUCTION TECHNOLOGY IN PLATELET CONCENTRATES
    Keil, S. D.
    Stormer, M.
    Brachert, J.
    Gathof, B.
    Goodrich, R. P.
    Marschner, S.
    Picker, S.
    Schneider, U.
    Schurig, U.
    Sicker, U.
    Montag, T.
    [J]. VOX SANGUINIS, 2011, 101 : 31 - 31
  • [49] Lymphocyte Survival and Activation in Stored Platelet Concentrates After Gamma-Irradiation or Pathogen Reduction Technology Treatment.
    Wozniak, Jol-anta J.
    Krzywdzinska, Agnieszka
    Lachert, Elzbieta
    Janik, Karolina
    Antoniewicz-Papis, Jolanta
    Kopec-Szlezak, Joanna
    Letowska, Magdalena
    [J]. BLOOD, 2009, 114 (22) : 833 - 833
  • [50] The combined effect of platelet storage media and intercept pathogen reduction technology on platelet activation/activability and cellular apoptosis/necrosis: Lisbon-RBS experience
    Carvalho, H
    Alguero, C
    Santos, M
    de Sousa, G
    Trindade, H
    Seghatchian, J
    [J]. TRANSFUSION AND APHERESIS SCIENCE, 2006, 34 (02) : 187 - 192
12345